Russell T Ray is Director of 180 Life Sciences Corp.. Currently has a direct ownership of 24,409 shares of ATNF, which is worth approximately $65,416. The most recent transaction as insider was on Sep 04, 2023, when has been sold 21,455 shares (Common Stock) at a price of $1.36 per share, resulting in proceeds of $29,178. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 24.4K
0% 3M change
0% 12M change
Total Value Held $65,416

RUSSELL T RAY Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 04 2023
BUY
Grant, award, or other acquisition
$29,178 $1.36 p/Share
21,455 Added 46.78%
24,409 Common Stock
Oct 31 2022
BUY
Grant, award, or other acquisition
-
30,702 Added 34.2%
59,068 Common Stock
Jul 27 2022
BUY
Grant, award, or other acquisition
-
13,068 Added 31.54%
28,366 Common Stock
May 19 2022
BUY
Grant, award, or other acquisition
$14,375 $1.36 p/Share
10,570 Added 50.0%
10,570 Common Stock
Jan 14 2022
BUY
Grant, award, or other acquisition
$14,373 $3.04 p/Share
4,728 Added 50.0%
4,728 Common Stock

Also insider at

MACK
MERRIMACK PHARMACEUTICALS INC Healthcare
RTR

Russell T Ray

Director
Palo Alto, CA

Track Institutional and Insider Activities on ATNF

Follow 180 Life Sciences Corp. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ATNF shares.

Notify only if

Insider Trading

Get notified when an 180 Life Sciences Corp. insider buys or sells ATNF shares.

Notify only if

News

Receive news related to 180 Life Sciences Corp.

Track Activities on ATNF